Activity-related variable . | Lifestyle (n = 536) . | Metformin (n = 543) . | Placebo (n = 543) . | P value* . |
---|---|---|---|---|
MV-intensity PA (min/day) | 20.7 (10.0–41.8) | 19.6 (8.6–36.6) | 19.6 (8.5–40.2) | 0.22 |
Light-intensity PA (min/day) | 363.5 (297.7–436.6) | 353.4 (286.7–417.6) | 353.2 (282.4–425.0) | 0.06 |
Total (MV + light) PA (min/day) | 389.4 (319.7–468.9) | 376.1 (308.4–450.7) | 377.4 (307.4–460.6) | 0.047 |
Total counts/day | 4,481 (3,419–5,729) | 4,264 (3,306–5,280) | 4,247 (3,130–599) | 0.045 |
Activity-related variable . | Lifestyle (n = 536) . | Metformin (n = 543) . | Placebo (n = 543) . | P value* . |
---|---|---|---|---|
MV-intensity PA (min/day) | 20.7 (10.0–41.8) | 19.6 (8.6–36.6) | 19.6 (8.5–40.2) | 0.22 |
Light-intensity PA (min/day) | 363.5 (297.7–436.6) | 353.4 (286.7–417.6) | 353.2 (282.4–425.0) | 0.06 |
Total (MV + light) PA (min/day) | 389.4 (319.7–468.9) | 376.1 (308.4–450.7) | 377.4 (307.4–460.6) | 0.047 |
Total counts/day | 4,481 (3,419–5,729) | 4,264 (3,306–5,280) | 4,247 (3,130–599) | 0.045 |
Data are median (IQR). Results are for ancillary study participants with valid accelerometer data (n = 1,622) measured once during DPPOS follow-up (mean 12 years). MV, moderate/vigorous.
Kruskal-Wallis P < 0.05 for differences between treatments.